Literature DB >> 30855278

Precision medicine and phenotypes, endotypes, genotypes, regiotypes, and theratypes of allergic diseases.

Ioana Agache1, Cezmi A Akdis2,3.   

Abstract

A rapidly developing paradigm for modern health care is a proactive and individualized response to patients' symptoms, combining precision diagnosis and personalized treatment. Precision medicine is becoming an overarching medical discipline that will require a better understanding of biomarkers, phenotypes, endotypes, genotypes, regiotypes, and theratypes of diseases. The 100-year-old personalized allergen-specific management of allergic diseases has particularly contributed to early awareness in precision medicine. Polyomics, big data, and systems biology have demonstrated a profound complexity and dynamic variability in allergic disease between individuals, as well as between regions. Escalating health care costs together with questionable efficacy of the current management of allergic diseases facilitated the emergence of the endotype-driven approach. We describe here a precision medicine approach that stratifies patients based on disease mechanisms to optimize management of allergic diseases.

Entities:  

Mesh:

Year:  2019        PMID: 30855278      PMCID: PMC6436902          DOI: 10.1172/JCI124611

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  124 in total

Review 1.  Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen).

Authors:  J Bousquet; N Khaltaev; A A Cruz; J Denburg; W J Fokkens; A Togias; T Zuberbier; C E Baena-Cagnani; G W Canonica; C van Weel; I Agache; N Aït-Khaled; C Bachert; M S Blaiss; S Bonini; L-P Boulet; P-J Bousquet; P Camargos; K-H Carlsen; Y Chen; A Custovic; R Dahl; P Demoly; H Douagui; S R Durham; R Gerth van Wijk; O Kalayci; M A Kaliner; Y-Y Kim; M L Kowalski; P Kuna; L T T Le; C Lemiere; J Li; R F Lockey; S Mavale-Manuel; E O Meltzer; Y Mohammad; J Mullol; R Naclerio; R E O'Hehir; K Ohta; S Ouedraogo; S Palkonen; N Papadopoulos; G Passalacqua; R Pawankar; T A Popov; K F Rabe; J Rosado-Pinto; G K Scadding; F E R Simons; E Toskala; E Valovirta; P van Cauwenberge; D-Y Wang; M Wickman; B P Yawn; A Yorgancioglu; O M Yusuf; H Zar; I Annesi-Maesano; E D Bateman; A Ben Kheder; D A Boakye; J Bouchard; P Burney; W W Busse; M Chan-Yeung; N H Chavannes; A Chuchalin; W K Dolen; R Emuzyte; L Grouse; M Humbert; C Jackson; S L Johnston; P K Keith; J P Kemp; J-M Klossek; D Larenas-Linnemann; B Lipworth; J-L Malo; G D Marshall; C Naspitz; K Nekam; B Niggemann; E Nizankowska-Mogilnicka; Y Okamoto; M P Orru; P Potter; D Price; S W Stoloff; O Vandenplas; G Viegi; D Williams
Journal:  Allergy       Date:  2008-04       Impact factor: 13.146

2.  T-helper type 2-driven inflammation defines major subphenotypes of asthma.

Authors:  Prescott G Woodruff; Barmak Modrek; David F Choy; Guiquan Jia; Alexander R Abbas; Almut Ellwanger; Laura L Koth; Joseph R Arron; John V Fahy
Journal:  Am J Respir Crit Care Med       Date:  2009-05-29       Impact factor: 21.405

Review 3.  Endotyping asthma: new insights into key pathogenic mechanisms in a complex, heterogeneous disease.

Authors:  Gary P Anderson
Journal:  Lancet       Date:  2008-09-20       Impact factor: 79.321

4.  Determining asthma treatment by monitoring sputum cell counts: effect on exacerbations.

Authors:  L Jayaram; M M Pizzichini; R J Cook; L-P Boulet; C Lemière; E Pizzichini; A Cartier; P Hussack; C H Goldsmith; M Laviolette; K Parameswaran; F E Hargreave
Journal:  Eur Respir J       Date:  2006-03       Impact factor: 16.671

Review 5.  Genetics and pharmacogenetics of the leukotriene pathway.

Authors:  Kelan G Tantisira; Jeffrey M Drazen
Journal:  J Allergy Clin Immunol       Date:  2009-08-08       Impact factor: 10.793

6.  Inflammatory subtypes in asthma: assessment and identification using induced sputum.

Authors:  Jodie L Simpson; Rodney Scott; Michael J Boyle; Peter G Gibson
Journal:  Respirology       Date:  2006-01       Impact factor: 6.424

7.  TBX21: a functional variant predicts improvement in asthma with the use of inhaled corticosteroids.

Authors:  Kelan G Tantisira; Eun Sook Hwang; Benjamin A Raby; Eric S Silverman; Stephen L Lake; Brent G Richter; Stanford L Peng; Jeffrey M Drazen; Laurie H Glimcher; Scott T Weiss
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-16       Impact factor: 11.205

8.  House dust mite extracts activate cultured human dermal endothelial cells to express adhesion molecules and secrete cytokines.

Authors:  Larry G Arlian; B Laurel Elder; Marjorie S Morgan
Journal:  J Med Entomol       Date:  2009-05       Impact factor: 2.278

9.  Genome-wide profiling identifies epithelial cell genes associated with asthma and with treatment response to corticosteroids.

Authors:  Prescott G Woodruff; Homer A Boushey; Gregory M Dolganov; Chris S Barker; Yee Hwa Yang; Samantha Donnelly; Almut Ellwanger; Sukhvinder S Sidhu; Trang P Dao-Pick; Carlos Pantoja; David J Erle; Keith R Yamamoto; John V Fahy
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-26       Impact factor: 11.205

10.  Analysis of induced sputum in adults with asthma: identification of subgroup with isolated sputum neutrophilia and poor response to inhaled corticosteroids.

Authors:  R H Green; C E Brightling; G Woltmann; D Parker; A J Wardlaw; I D Pavord
Journal:  Thorax       Date:  2002-10       Impact factor: 9.139

View more
  40 in total

Review 1.  Hot Topic: Precision Medicine for Asthma-Has the Time Come?

Authors:  Xingnan Li
Journal:  Curr Allergy Asthma Rep       Date:  2019-09-05       Impact factor: 4.806

2.  Introducing the Endotype Concept to Address the Challenge of Disease Heterogeneity in Type 1 Diabetes.

Authors:  Manuela Battaglia; Simi Ahmed; Mark S Anderson; Mark A Atkinson; Dorothy Becker; Polly J Bingley; Emanuele Bosi; Todd M Brusko; Linda A DiMeglio; Carmella Evans-Molina; Stephen E Gitelman; Carla J Greenbaum; Peter A Gottlieb; Kevan C Herold; Martin J Hessner; Mikael Knip; Laura Jacobsen; Jeffrey P Krischer; S Alice Long; Markus Lundgren; Eoin F McKinney; Noel G Morgan; Richard A Oram; Tomi Pastinen; Michael C Peters; Alessandra Petrelli; Xiaoning Qian; Maria J Redondo; Bart O Roep; Desmond Schatz; David Skibinski; Mark Peakman
Journal:  Diabetes Care       Date:  2019-11-21       Impact factor: 19.112

3.  Delirium Severity Trajectories and Outcomes in ICU Patients. Defining a Dynamic Symptom Phenotype.

Authors:  Heidi Lindroth; Babar A Khan; Janet S Carpenter; Sujuan Gao; Anthony J Perkins; Sikandar H Khan; Sophia Wang; Richard N Jones; Malaz A Boustani
Journal:  Ann Am Thorac Soc       Date:  2020-09

Review 4.  Different Phenotypes in Asthma: Clinical Findings and Experimental Animal Models.

Authors:  Luiz Otávio Lourenço; Alessandra Mussi Ribeiro; Fernanda Degobbi Tenório Quirino Dos Santos Lopes; Iolanda de Fátima Lopes Calvo Tibério; Wothan Tavares-de-Lima; Carla Máximo Prado
Journal:  Clin Rev Allergy Immunol       Date:  2021-09-20       Impact factor: 8.667

5.  TLR5 Activation Exacerbates Airway Inflammation in Asthma.

Authors:  G S Whitehead; S Hussain; R Fannin; C S Trempus; C L Innes; S H Schurman; D N Cook; S Garantziotis
Journal:  Lung       Date:  2020-02-14       Impact factor: 2.584

6.  TNF induces production of type 2 cytokines in human group 2 innate lymphoid cells.

Authors:  Noriko Ogasawara; Julie A Poposki; Aiko I Klingler; Bruce K Tan; Kathryn E Hulse; Whitney W Stevens; Anju T Peters; Leslie C Grammer; Kevin C Welch; Stephanie S Smith; David B Conley; Ken-Ichi Takano; Tetsuo Himi; Robert C Kern; Robert P Schleimer; Atsushi Kato
Journal:  J Allergy Clin Immunol       Date:  2019-09-14       Impact factor: 10.793

7.  Epithelial miR-206 targets CD39/extracellular ATP to upregulate airway IL-25 and TSLP in type 2-high asthma.

Authors:  Kan Zhang; Yuchen Feng; Yuxia Liang; Wenliang Wu; Chenli Chang; Dian Chen; Shengchong Chen; Jiali Gao; Gongqi Chen; Lingling Yi; Dan Cheng; Guohua Zhen
Journal:  JCI Insight       Date:  2021-06-08

8.  Treatable Mechanisms in Asthma.

Authors:  Mario Cazzola; Josuel Ora; Francesco Cavalli; Paola Rogliani; Maria Gabriella Matera
Journal:  Mol Diagn Ther       Date:  2021-02-11       Impact factor: 4.074

9.  Distinct immunologic endotypes are associated with clinical trajectory after severe blunt trauma and hemorrhagic shock.

Authors:  Scott C Brakenridge; Zhongkai Wang; Michael Cox; Steven Raymond; Russell Hawkins; Dijoia Darden; Gabriela Ghita; Babette Brumback; Joseph Cuschieri; Ronald V Maier; Frederick A Moore; Alicia M Mohr; Philip A Efron; Lyle L Moldawer
Journal:  J Trauma Acute Care Surg       Date:  2021-02-01       Impact factor: 3.313

10.  Oleoylethanolamide induces eosinophilic airway inflammation in bronchial asthma.

Authors:  Eun-Kyung Kwon; Youngwoo Choi; Il-Hee Yoon; Ha-Kyeong Won; Soyoon Sim; Hee-Ra Lee; Hyoung Su Kim; Young-Min Ye; Yoo Seob Shin; Hae-Sim Park; Ga-Young Ban
Journal:  Exp Mol Med       Date:  2021-06-02       Impact factor: 8.718

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.